EARLIER this month Dr Byram Bridle, a Canadian viral immunologist whose faculty at the University of Ontario has disowned him for his repeated assertion that Covid-19 vaccines are not safe, gave a remarkable off-the-cuff interview to a reporter. We’re publishing edited extracts from the transcript today, tomorrow and Saturday. Bridle starts by explaining the reasons why heavily vaccinated countries are experiencing high case rates, why adverse reactions are not being reported or diagnosed and discusses the overwhelming evidence for ivermectin as an ant-viral treatment for Covid where studies have been conducted correctly.
You can watch the full video and read the first part of the transcript below.
DR BYRAM BRIDLE: A recent study came out looking at 68 different countries and they plotted on a graph the case rate for Covid-19 and the vaccination rate in the country. And the more vaccinated the country is, the more problems they’re having with Covid-19. So these people have the vaccine. Remember all the antibody titers they’re showing, that’s in the blood, but these people, on average, are quite poorly protected in their upper airways. And it’s not the virus that’s deep down in the alveoli that gets transmitted to other people because of the dead airspace when we exhale. It’s the viral particles that are in the upper airways. So that’s why the vaccinated can spread this just as efficiently as somebody who’s completely unprotected. And so these vaccines on that basis, because they don’t come close to conferring sterilising immunity, they don’t properly protect the upper respiratory tract, they only confer about four and a half months of immunity, it’s absolutely 100 per cent impossible to achieve the goal of herd immunity with these vaccines. 100 per cent impossible.
What I’ve seen way too much of – and it does cause me very serious concern – is we’re seeing people who had cancers that were in remission or that were being well-controlled, and their cancers have gone completely out of control after getting the vaccine. And what we do know with the vaccine is the vaccine causes at least a temporary drop in T-cell numbers and those T-cells are part of our immune system, and they’re the critical weapons that our immune system has to fight off cancerous cells. So there’s a potential mechanism there. And all I can say is I’ve seen . . . I’ve had people contact me with way too many of these reports for me to feel comfortable. I do feel that that’s probably, I would say, my newest major safety concern. And it’s also the one that is going to be by far the most underreported on any adverse event database. Because if somebody’s had a cancer before the vaccine, there’s no way public health officials will ever link it to the vaccine. But what we’re seeing is oncology teams that had pushed the cancers into remission or keeping them well-controlled can no longer control them after the vaccine.
So we know in Canada it’s very upsetting, because in Canada we have a system that will never, never detect problems with these vaccines – that’s why we’ve always had to rely on other countries. Like with the AstraZeneca vaccine, we told Canadians that the AstraZeneca vaccine was 100 per cent safe, despite the fact that 12 European countries had paused the programme to look for potential links to the blood clotting, potentially fatal blood clotting. And we were told as Canadians that we didn’t have to worry because ours was from a . . . they announced that the problem was associated with a single batch from a single production facility in Europe and ours was coming from India and therefore it didn’t apply to us. The European Medicines Agency will tell you that was never the case. And of course, then eventually, after there were Canadians that did die and many that did have to be treated for the blood clots, then we finally admitted that it was a problem.
And that’s how our system . . . our system is never going to work, because this is the thing. First of all, we’re not informing people when they get the vaccine that they’re to report any unusual medical condition up to eight weeks after receiving a dose of the vaccine. And then the attending physician is required to, by law, to report anything unusual. Most physicians are not. And now some of them are . . . many don’t, because they don’t want to contradict the current narrative. And the College of Physicians and Surgeons of Ontario has turned out to be incredibly tyrannical and are crushing many physicians and threatening many who don’t go with this narrow public health narrative. Many also can’t get their submissions done because they’re onerous. So, for example, British Columbia can take up to 40 minutes to submit one of these reports, and you can imagine if there’s an Emergency Room physician who sees five people in a shift that come in with problems and have recently been vaccinated, they can’t afford to spend hours on that shift, reporting it, right?
So there’s many reasons why people aren’t reporting to the physicians, and there are many reasons why the physicians aren’t reporting to the local Medical Officer of Health. And that’s the next step is, if a physician submits it, it doesn’t necessarily go into our database, it goes to the local Medical Officer of Health. This is the thing: the physicians are not supposed to make a determination of whether they think the medical condition that’s occurred after the vaccine is or is not related to the vaccine. They’re not supposed to make that determination. The local Medical Officers of Health are. And as you can imagine, with the huge bias that exists there, the majority of them, we’re seeing unusually high percentages of these reports that do get submitted being rejected at the level of the local Medical Officer of Health. And then from there, the ones that they do approve go to the Public Health Agency of Canada and then they could be filed into our adverse event database. But because of that, because of all the filtering that’s going on, this is the problem. We’re not getting accurate numbers.
So yes, a statistician, of course, could be looking for these. But if you don’t get accurate numbers reported, you can do all the analysis you want, it’s not going to be accurate, right? Your analysis is only as accurate as the data, the raw data you have to work with.
A D-dimer test is definitely a good one to do, because it can be suggestive of micro clots, which could be an indicator of blood clotting. But yeah, we’re finding that most physicians won’t do it. And we’re also finding a shortage, actually, of the blood collection tubes that are needed to do that as well.
Yeah, yeah, no, this is a virus. But ivermectin has clear-cut antiviral properties. For example, it has multiple mechanisms of action, but one is it inhibits the binding of the spike protein on the virus to these receptors that we have on the cells of our lungs. And yeah, what’s interesting is a lot of countries . . . so, that’s what’s frustrating for me as a vaccine developer, I knew that there was going to be no outlet for the vaccines if there were effective early treatment strategies. So I followed the science for the early treatment strategies, and I saw that the studies were flawed early on.
For example, a lot of the studies that were being done were being done in countries where things like ivermectin were available over the counter. So in other words, they were testing their treatment group, which was getting a defined amount of ivermectin and comparing it to a control group which had an undefined amount of ivermectin. So essentially comparing ivermectin treatment to ivermectin treatment, right? And then they showed there was no benefit. Well, of course not. If you’re comparing, you know, a treatment group to a treatment group.
And so when the science has been done properly, there’s an overwhelming [body] of scientific data showing that it works. And so even though I love vaccines, I couldn’t help but wonder why we were providing initially this authorisation for interim use, what we call emergency use in the United States, because we had clear, effective early treatments. I have worked with many physicians. These things clearly work. In fact, a lot of the countries that are having the most success, like, for example, a lot of the low income countries have had no choice. I mean, look, they’ve been left to take the leftovers for the vaccines. They can’t afford a lot of expensive treatments. So they have been relying on these effective early treatment strategies using repurposed generic drugs that are really cheap, and they’ve had a huge success.
So, for example, Egypt is a good example. Egypt, you know, Egypt has a three per cent vaccination rate. Three per cent of their eligible population is double vaccinated compared with Canada, which is at around 64 or 66 per cent. And they have 14 cases of Covid-19 per 100,000 people per day on average, whereas we have about 570 cases per day, so vastly higher.
And this is what people are seeing. A recent study came out looking at 68 different countries, and they plotted on a graph the case rate for Covid-19 and the vaccination rate in the country. And the more vaccinated the country is, the more problems they’re having with Covid-19. And when you look at these countries that have low vaccination rates, they’ve been relying on effective early treatment strategies.
So for example, with Egypt, I didn’t realise, but I asked that question to my collaborators, ‘What is Egypt doing right that we’re not doing here in North America?’ They sent me the official treatment protocol for Covid-19. Do you know what the number one thing is that they go to first? [It] is hydroxychloroquine and number two is ivermectin.
And if you look at Israel – Israel has the highest vaccination rate in the world, right? And the Delta variant is completely out of control, which is why they’ve been administering the third dose, why they’ve committed to a fourth dose. And with these numbers I was telling you, so they have the highest vaccination rates. So again, keep this in mind so as to understand – Egypt: three per cent vaccination rate, 14 cases per 100,000 of the population per day. Israel is at over an 80 per cent vaccination rate and has over 5,000 cases right now per day.
So these things work best as an early treatment strategy, so they should be administered. The sooner you administer them, the better the outcome. So we’ve had physicians – and I know these people and they’re good friends of mine – who have been absolutely destroyed for using ivermectin with their patients, and they’ve kept their patients out of the hospital, they’ve kept them out of the ICU. I find this exceptionally frustrating because I keep getting criticised for raising my concerns about the vaccines and harms, and I have physicians coming at me and saying, ‘Well, if only you saw on the front lines what happens to people who die from Covid and how terrible it is.’ And yes, it’s awful, and I feel terrible for all of them. But the other thing that I point out is it’s estimated that more than half the people that have died in this pandemic would be alive today if we had accepted these early treatment strategies. That’s the reality, and I’ve seen it with every physician who has administered this. They talk about our ICUs being overrun, but every physician that I have worked with – and I’ve worked with many who have used these effective treatment strategies – they’ve kept their patients out of the ICU. They don’t go to the ICU and they don’t die.
Do you realise that the way we’ve been treating patients is they go to the hospital and if they aren’t sick enough to go on a respirator, they typically get sent home and it’s, you know, take fluids and some of these other . . . maybe some aspirin. It’s basically what were they like to call in medicine, ‘watchful waiting’, which means, ‘we’re going to do nothing’, right? And you literally have to wait till you’re sick enough to come in and basically be put in the ICU and put on a respirator.
That’s not how you treat disease, right? The earlier you intervene, the better the outcome. And we have these early treatment strategies, and I think it’s no coincidence the only one we’ve approved in Canada is called remdesivir. It does have genuine safety issues and does virtually nothing for Covid-19. But it’s on patent and there’s tons of money that can be made. These other ones are dirt cheap. Ivermectin, you can treat somebody for about a dollar a day. So they’ve been using it to great effect in all these low income countries. But in North America, we’ve refused to adopt these strategies.
And you have to understand, and they even talk about safety issues. Well, one of the things is, so, there’s rare cases of safety issues associated with using the veterinary form, and that’s simply because of calculation errors – people making simple mathematical errors when trying to convert to the human dose. And the reality is that ivermectin is on the list for the World Health Organisation of one of the 50 most needed drugs in the entire world, has an unbelievable safety record. It’s used worldwide to effectively treat all these parasitic diseases. It was approved by Health Canada in 2018 to treat exotic parasitic diseases when Canadians are travelling. And so there’s absolutely no excuse.
In the second section Dr Bridle discusses the pressure put on him by other physicians to fall into line, the burden of responsibility they bear given the levels of public trust put in them; they are promoting the vaccines though they don’t understand the science.